These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 37249700)
1. Surgery as first-line treatment for prolactinoma? Discussion of the literature and results of a consecutive series of surgically treated patients. Ottenhausen M; Conrad J; Wolters LM; Ringel F Neurosurg Rev; 2023 May; 46(1):128. PubMed ID: 37249700 [TBL] [Abstract][Full Text] [Related]
2. Endocrinological outcomes of pure endoscopic transsphenoidal surgery: a Croatian Referral Pituitary Center experience. Marić A; Kruljac I; Čerina V; Pećina HI; Šulentić P; Vrkljan M Croat Med J; 2012 Jun; 53(3):224-33. PubMed ID: 22661135 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Endoscopic Transsphenoidal Resection for Prolactinoma: A Retrospective Multicenter Case-series. Zandbergen IM; Huntoon KM; White TG; Bakker LEH; Verstegen MJT; Ghalib LM; van Furth WR; Pelsma ICM; Dehdashti AR; Biermasz NR; Prevedello DM Arch Med Res; 2023 Dec; 54(8):102919. PubMed ID: 38040527 [TBL] [Abstract][Full Text] [Related]
4. Transsphenoidal surgery for pituitary adenomas in pediatric patients: a multicentric retrospective study. Locatelli D; Veiceschi P; Castelnuovo P; Tanriover N; Evliyaoglu O; Canaz H; Ugurlar D; Gazioglu N Childs Nerv Syst; 2019 Nov; 35(11):2119-2126. PubMed ID: 31079182 [TBL] [Abstract][Full Text] [Related]
5. Long-term Outcome of Microscopic Transsphenoidal Surgery for Prolactinomas as an Alternative to Dopamine Agonists. Park K; Park KH; Park HR; Lee JM; Kim YH; Kim DY; Won TB; Kong SH; Kim JH; Shin CS; Paek SH J Korean Med Sci; 2021 Apr; 36(15):e97. PubMed ID: 33876586 [TBL] [Abstract][Full Text] [Related]
6. Preoperative treatment with dopamine agonist therapy influences surgical outcome in prolactinoma: a retrospective single-center on 159 patients. Ryba A; Gonzalez Lopez D; Rotermund R; Flitsch J Acta Neurochir (Wien); 2024 Aug; 166(1):316. PubMed ID: 39085706 [TBL] [Abstract][Full Text] [Related]
7. Transnasal surgery for prolactin-secreting pituitary adenomas in childhood and adolescence. Abe T; Lüdecke DK Surg Neurol; 2002 Jun; 57(6):369-78; discussion 378-9. PubMed ID: 12176193 [TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of female prolactinoma patients at child-bearing age after transsphenoidal surgery. Yi N; Ji L; Zhang Q; Zhang S; Liu X; Shou X; Lu B Endocrine; 2018 Oct; 62(1):76-82. PubMed ID: 29934876 [TBL] [Abstract][Full Text] [Related]
9. Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients. Kreutzer J; Buslei R; Wallaschofski H; Hofmann B; Nimsky C; Fahlbusch R; Buchfelder M Eur J Endocrinol; 2008 Jan; 158(1):11-8. PubMed ID: 18166812 [TBL] [Abstract][Full Text] [Related]
10. Microscopic endonasal transsphenoidal pituitary adenomectomy in the pediatric population. Tarapore PE; Sughrue ME; Blevins L; Auguste KI; Gupta N; Kunwar S J Neurosurg Pediatr; 2011 May; 7(5):501-9. PubMed ID: 21529190 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases. Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847 [TBL] [Abstract][Full Text] [Related]
12. SURGICAL OUTCOMES OF PROLACTINOMAS IN RECENT ERA: RESULTS OF A HETEROGENOUS GROUP. Donegan D; Atkinson JL; Jentoft M; Natt N; Nippoldt TB; Erickson B; Meyer F; Erickson D Endocr Pract; 2017 Jan; 23(1):37-45. PubMed ID: 27682355 [TBL] [Abstract][Full Text] [Related]
13. Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas. Shimon I; Sosa E; Mendoza V; Greenman Y; Tirosh A; Espinosa E; Popovic V; Glezer A; Bronstein MD; Mercado M Pituitary; 2016 Aug; 19(4):429-36. PubMed ID: 27138902 [TBL] [Abstract][Full Text] [Related]
14. Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients. Primeau V; Raftopoulos C; Maiter D Eur J Endocrinol; 2012 May; 166(5):779-86. PubMed ID: 22301915 [TBL] [Abstract][Full Text] [Related]
15. Endoscopic Transsphenoidal Surgery of Microprolactinomas: A Reappraisal of Cure Rate Based on Radiological Criteria. Micko A; Vila G; Höftberger R; Knosp E; Wolfsberger S Neurosurgery; 2019 Oct; 85(4):508-515. PubMed ID: 30169711 [TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics and Outcomes of Prolactinomas in Children and Adolescents: A Large Retrospective Cohort Study. Yang Y; Ke X; Duan L; Yang H; Gong F; Pan H; Wang L; Zhu H J Clin Endocrinol Metab; 2024 Aug; 109(9):e1741-e1749. PubMed ID: 38164002 [TBL] [Abstract][Full Text] [Related]
18. The Combination of Dopamine Agonist Treatment and Surgery May Be the Best Option in Challenging Prolactinoma Cases: A Single-Centre Experience. Demir D; Demir AN; Sulu C; Zulfaliyeva G; Cetintas SC; Ozkaya HM; Kadioglu P; Gazioglu N; Tanriover N World Neurosurg; 2023 Jul; 175():e1166-e1174. PubMed ID: 37120141 [TBL] [Abstract][Full Text] [Related]
19. Transsphenoidal surgery for a life-threatening prolactinoma apoplexy during pregnancy. Witek P; Zieliński G; Maksymowicz M; Zgliczyński W Neuro Endocrinol Lett; 2012; 33(5):483-8. PubMed ID: 23090264 [TBL] [Abstract][Full Text] [Related]
20. Endoscopic Endonasal Approach to Giant Pituitary Adenomas: Surgical Outcomes and Review of the Literature. Rahimli T; Hidayetov T; Yusifli Z; Memmedzade H; Rajabov T; Aghayev K World Neurosurg; 2021 May; 149():e1043-e1055. PubMed ID: 33524611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]